Exin Therapeutics
PrivateLast Round
Seed
Feb 10, 2026
Total Funding Raised
$3.16M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Exin Therapeutics is a biotechnology company that develops an AI-driven drug discovery platform and genetic therapies to target neurological and neuropsychiatric disorders.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Exin Therapeutics Comparables
Compare Exin Therapeutics with similar companies based on industry and business-model similarity.
Exin Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 10, 2026 | ||||
| Seed | May 20, 2025 | ||||
| Accelerator | Jan 1, 2025 |
Key People
Founding team and executive leadership
Exin Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Y Combinator | Accelerator, Seed |
| Tekedia Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors grew 118% MoM.
- Aug 22, 2026
Monthly visitors increased 30% MoM, reaching 1K.
Exin Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Exin Therapeutics's valuation, stock price, and market status.
Is Exin Therapeutics a public or private company?
Exin Therapeutics is a private company.
What is the current stock price of Exin Therapeutics?
Exin Therapeutics is a private company, so its shares have no public market price. Caplight tracks Exin Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Exin Therapeutics worth (valuation)?
Valuation information for Exin Therapeutics is not publicly available.
Can I buy Exin Therapeutics stock?
Exin Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Exin Therapeutics's last funding round?
Exin Therapeutics's most recent funding round was Seed on February 10, 2026.
Who are the main investors in Exin Therapeutics?
Key investors in Exin Therapeutics include Y Combinator.
Will Exin Therapeutics IPO soon?
No public IPO plans have been announced for Exin Therapeutics.
How can I track Exin Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Exin Therapeutics's shares on secondary markets.